Skip to main content
. 2019 Jun 12;14(6):e0216139. doi: 10.1371/journal.pone.0216139

Fig 9. OAS1 expression of IFNβ-treated cells pre-incubated with CDM-3008 or IFNα.

Fig 9

PXB cells were pretreated with 30 μM CDM-3008 (CDM) or 10 ng/ml IFNα for 24 h and then treated with 10 ng/ml IFNβ for 4 h. mRNA expression levels of OAS1 were compared. The error bars indicate S.D. (n = 3). *, p < 0.05; **, p < 0.01; N.S., not significant (two-tailed t-test).